false000180034700018003472023-10-102023-10-100001800347us-gaap:CommonClassAMember2023-10-102023-10-100001800347us-gaap:WarrantMember2023-10-102023-10-10

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): October 10, 2023

E2open Parent Holdings, Inc.

(Exact Name of Registrant as Specified in Charter)

Delaware

001-39272

86-1874570

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

9600 Great Hills Trail, Suite 300E

Austin, TX

(address of principal executive offices)

78759

(zip code)

866-432-6736

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, par value $0.0001 per share

ETWO

New York Stock Exchange

Warrants to purchase one share of Class A Common Stock

    at an exercise price of $11.50

ETWO-WT

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


 


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Management Transition

On October 10, 2023, E2open Parent Holdings, Inc. (the “Company” or “E2open”) and Mr. Michael A. Farlekas agreed that Mr. Farlekas would depart the Company as an employee and cease serving as its Chief Executive Officer (“CEO”) and on its board of directors (the “Board”). The Board has appointed Mr. Andrew Appel as interim CEO (“Interim CEO”) and a director of the Company.

Mr. Appel, 58, has served on E2open's Advisory Board since 2022 and brings over twenty-five years of management experience and extensive expertise in business strategy and innovation for the technology industry. Mr. Appel previously served for nearly a decade as President and CEO at IRI (now Circana), the leading provider of big data, predictive analytics, and forward-looking insights solutions for consumer-packaged goods brands, retailers, and media companies. Before joining IRI, he served as Chief Revenue Officer of Accretive Health, Chief Operating Officer of Aon, and was a Senior Partner at McKinsey & Company. He serves as Lead Director on the Board of Constant Contact, is a member of the Board of Advisors for the UCLA Anderson School of Management, and currently serves on the advisory boards of multiple leading data and technology companies. He previously served on the board of IRI, Machine Vantage, and Alight, the world's leading human capital administration firm. Mr. Appel holds a bachelor’s degree in economics from the University of California, Los Angeles, and an MBA from the University of Chicago, where he was the Henry Ford II Scholar.

Mr. Appel has no family relationships with any of the Company’s directors or executive officers, and he has no direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K. Other than as described in this Form 8-K, there are no arrangements or understandings between Mr. Appel and any other persons pursuant to which he was appointed as Interim CEO or as a director of the Company.

Separation Agreement

On October 10, 2023, the Company and Mr. Farlekas entered into a Release and Non-Competition Agreement (the “Separation Agreement”). Pursuant to the Separation Agreement, Mr. Farlekas’ employment with the Company ended on October 10, 2023 (the “Separation Date”).

In addition to certain other cooperation obligations, Mr. Farlekas will remain available following the Separation Date to provide certain consulting and transition services to the Company and its affiliates until December 31, 2023 (the “Consulting Period”). During the Consulting Period, Mr. Farlekas will not receive any compensation or benefits for providing such transition services, other than the severance benefits and incentive equity treatment summarized below.

Subject to Mr. Farlekas’ continued compliance with the provisions of the Separation Agreement, Mr. Farlekas will receive the severance benefits set forth in Article III of the E2open Parent Holdings, Inc. Executive Severance Plan (the “Severance Plan”), in accordance with the terms of the Severance Plan. A summary of the material terms of the Severance Plan is contained in the Company’s proxy statement for the 2023 annual meeting of stockholders (the “2023 Proxy Statement”) under the heading “Potential Payments Upon Termination or Change-in-Control,” which was filed with the U. S. Securities and Exchange Commission (the “SEC”) on May 26, 2023.

In addition, subject to Mr. Farlekas’ continued compliance with the provisions of the Separation Agreement, Mr. Farlekas’ outstanding incentive equity awards will be treated in accordance with his existing agreements governing such equity.

The Separation Agreement includes a customary release of claims by Mr. Farlekas in favor of the Company and its affiliates, as well as other customary provisions relating to confidentiality and restrictive covenants.

The foregoing description of the Separation Agreement is qualified in its entirety by reference to the complete terms of the Separation Agreement which is filed as Exhibit 10.1 to this Form 8-K. The description of the Severance Plan is qualified in its entirety by reference to the complete terms of the Executive Severance Plan, dated as of February 4,

2


 

2021, by and among E2open Parent Holdings, Inc. and the executive named therein, which was filed as Exhibit 10.15 to the Company’s Annual Report on Form 10-K filed on May 20, 2021.

Employment Agreement

On October 10, 2023 (the “Appointment Date”), the Board appointed Mr. Andrew Appel as Interim CEO of the Company and a director on the Board. The Company and Mr. Appel entered into a letter agreement on the Appointment Date (the “Letter Agreement”), pursuant to which Mr. Appel will serve as Interim CEO for an initial six-month term commencing on the Appointment Date (the “Initial Term”), subject to automatic monthly renewals (each, a “Renewal Term”) unless the Company or Mr. Appel provide written notice of non-extension at least 15 days before the end of the Initial Term or any Renewal Term. Either party may terminate Mr. Appel’s employment at any time; provided, that, the Company must provide 15 days’ prior notice in the event of a termination without Cause (as defined in the Letter Agreement).

While serving as Interim CEO, Mr. Appel will devote approximately 50% of his business time to the Company. The Letter Agreement provides for an aggregate base salary equal to $500,000 during the Initial Term and a monthly base salary of $83,333 after expiration of the Initial Term.

As soon as practicable following the Appointment Date, subject to Board approval, Mr. Appel will receive an initial grant of restricted shares (the “Initial Restricted Stock Grant”) under the E2open 2021 Omnibus Incentive Plan (the “Plan”) having an initial grant date value equal to approximately $685,000. Additionally, after the expiration of the Initial Term, subject to Board approval, during each Renewal Term, Mr. Appel will receive monthly grants of restricted shares (each, a “Monthly Restricted Stock Grant”) under the Plan, each having a grant date value equal to approximately $100,000. The Initial Restricted Stock Grant and each Monthly Restricted Stock Grant will be issued pursuant to an award agreement and will vest (x) in the case of the Initial Restricted Stock Grant, on the six-month anniversary of the Appointment Date, and (y) in the case of each Monthly Restricted Stock Grant, on the one-month anniversary of such Monthly Restricted Stock Grant, provided, that, the Initial Restricted Stock Grant and each Monthly Restricted Stock Grant will vest in full on the occurrence of the earlier of a Change in Control (as defined in the Plan) or termination of Mr. Appel’s employment with the Company without Cause (as defined in the Plan).

In the event Mr. Appel’s employment is terminated by the Company for any reason other than for Cause, subject to his execution and non-revocation of a general release of claims, (x) if such termination occurs prior to the expiration of the Initial Term, (A) Mr. Appel will receive an amount equal to the balance of any base salary that remains unpaid as of the date of termination that would have otherwise been payable in respect of the Initial Term and (B) any portion of the Initial Restricted Stock Grant that has been granted that remains unvested as of the date of termination will become fully vested as of the date of termination; (y) if such termination occurs during any Renewal Term, any portion of any Monthly Restricted Stock Grant that has been granted that remains unvested as of the date of termination will become fully vested as of the date of termination; and (z) if such termination occurs at any time during the term of employment, Mr. Appel will receive continued COBRA coverage until the later of (a) 12 months from date of termination or (b) December 31, 2024 (provided that such coverage will cease in the event Mr. Appel obtains employment that offers group health benefits).

During the term of employment, Mr. Appel is prohibited from commencing any engagement or otherwise providing services to any company, entity or enterprise engaged in the business of providing cloud-based, end-to-end omni-channel and supply chain management and orchestration software. The Letter Agreement also contains a perpetual confidentiality covenant.

Pursuant to the Letter Agreement, Mr. Appel agreed his board service advisory service agreements with the Company would be terminated as of the Appointment Date such that he would no longer be entitled to any cash, equity or other compensation thereunder following the Appointment Date, provided, that, any equity awards granted thereunder that were outstanding as of immediately prior to the Appointment Date would continue to vest during his term of employment or service with the Company.

The foregoing description of the Letter Agreement is qualified in its entirety by reference to the complete terms of the Letter Agreement, which is filed as Exhibit 10.2 to this Form 8-K. The description of the Plan is qualified in its entirety by reference to the complete terms of the E2open Parent Holdings, Inc. 2021 Omnibus Incentive Plan, As Amended

3


 

and Restated, which was filed as Exhibit 10.18 to the Company’s Annual Report on Form 10-K filed on April 29, 2022.

Item 7.01 Regulation FD Disclosure.

On October 10, 2023, the Company issued a press release announcing the appointment of Mr. Appel. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

The information in Item 7.01, including the exhibit hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated into any registration statement or other filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

Exhibits.

Exhibit Number

 

Description

10.1

Release and Non-Competition Agreement, by and between E2open Parent Holdings, Inc. and Michael A. Farlekas, dated as of October 10, 2023

10.2

Letter Agreement, by and between E2open Parent Holdings, Inc. and Andrew Appel, dated as of October 10, 2023

10.3

Restricted Stock Agreement for Andrew Appel dated as of October 10, 2023

99.1*

Press Release, dated as of October 10, 2023

104

Cover Page Interactive Data File (formatted in Inline XBRL)

* Furnished herewith

4


 

SIGNATURE

 

Pursuant to the Requirements of the Securities Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

 

E2open Parent Holdings, Inc.

Date: October 10, 2023

By:

/s/ Jennifer S. Grafton

Jennifer S. Grafton

Executive Vice President and General Counsel

 

5


Exhibit 10.1

Release and Non-Competition Agreement

This Release and Non-Competition Agreement (“Agreement”), is entered into by and between E2open Parent Holdings, Inc. (collectively with its Affiliates and their subsidiaries, the “Company”) and Michael Farlekas (“Executive”). The Company and Executive will be jointly referred to as the “Parties.” Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to such terms in the E2open Parent Holdings, Inc. Executive Severance Plan (the “Plan”).

WHEREAS, Executive and E2open, LLC, a Delaware limited liability company and subsidiary of the Company, are party to that certain Employment Letter Agreement, dated as of March 1, 2021 (the “Employment Agreement”);

WHEREAS, the Plan Administrator of the Plan has determined that Executive is an Eligible Employee under the terms of the Plan;

WHEREAS, the Plan requires Executive to sign and not revoke this Agreement in accordance with its terms in order to be eligible for the benefits under the Plan; and

WHEREAS, Executive has carefully read and fully understands all of the provisions and effects of this Agreement, which includes a general release and post-employment restrictions on Executive.

NOW, THEREFORE, Executive and the Company, for the good and sufficient consideration set forth below and intending to be legally bound, agree as follows:

1.
Separation from Employment/Consulting Services.
(a)
Executive has provided notice of Executive’s resignation from employment with the Company, with such resignation and employment termination to be effective at the end of the day on October 10, 2023 (the “Separation Date”). Regardless of whether Executive signs this Agreement, Executive will be paid for all of Executive’s accrued but unused paid time off through the Separation Date. The Company will also pay Executive for all properly reported and reimbursable expenses incurred prior to the Separation Date. Following the Separation Date, Executive shall not be, or represent that Executive is, an employee, agent, or representative of the Company, any of the other Company Releasees (as defined below), or any of their respective funds or portfolio companies and Executive shall take any actions required by the Company to effectuate the foregoing. Further, Executive will immediately and without the need for any additional action be deemed to have resigned from all directorships, committee memberships, officer positions and any other positions that Executive holds with the Company Group (as defined below), and agrees to take any actions as may be reasonably required to effectuate the foregoing. Executive’s execution of this Agreement will be deemed the grant by Executive to the officers of the Company of a limited power of attorney to sign in Executive’s name and on Executive’s behalf any such documentation as may be required to be executed solely for the limited purposes of effectuating such resignations.

4855-3238-1311v.2


(b)
Notwithstanding the foregoing, and without limiting Executive’s obligations under Section 17 of this Agreement, the Parties may refer to Executive as a “Consultant,” for purposes of internal Company communications, until December 31, 2023 (“Consulting Period”). For the avoidance of doubt, during such time, Executive shall not, unless otherwise agreed by the Executive and an authorized member of the Company’s Board of Directors in writing (including as specified in this Agreement below): (i) perform any work for the Company or its affiliates, (ii) report to the Company’s offices, (iii) attend any events or engagements of the Company or its affiliates, (iv) incur any expenses or create any obligations on behalf of the Company or its affiliates, or (v) speak with any employees, officers, advisors, clients, or other business relations of the Company or any of its affiliates (other than the Interim Chief Executive Officer) about any matters related to the business of the Company or its affiliates. Rather, during the Consulting Period, and without limiting Executive’s obligations under Section 17 of this Agreement, Executive shall, during normal business hours: (A) assist the Company with the transition of Executive’s roles, duties and responsibilities to Executive’s successor(s) (“Transition Matters”); (B cooperate with respect to the implementation of a transition and communication plan as reasonably requested by the Interim Chief Executive Officer, to help the Company retain existing customers and solicit new customers (which shall involve travel and in-person meetings), and may be referred to as a “Strategic Advisor” during the Consulting Period for purposes of such written transition and communication plan and external Company communications with existing and new customers; and, (C) honor the terms of this Agreement, including Section 17 of this Agreement. Executive shall not be entitled to receive any compensation or benefits for providing such services other than as set forth in Section 2 below, except for reasonable business expenses incurred in accordance with Company policy by Executive at the direction of the Company or as agreed by Executive. Any breach of this provision or of this Agreement shall constitute Cause under the Plan and render Executive ineligible for any consideration under Section 2 below or otherwise. Should the Company request Executive to perform any services after the Consulting Period, such services will be performed by Executive pursuant to a written, signed agreement and statement of work that details the compensation to be provided by the Company to Executive for such services.
2.
Severance Benefits. As of the Effective Date of this Agreement set forth below, and subject to Executive’s continued compliance with the provisions of this Agreement, notwithstanding Executive’s resignation of employment as described in Section 1(a), Executive will receive the benefits set forth in Article III of the Plan, as applicable, in accordance with the terms of the Plan including but not limited to the Limitation on Payments in Article IV, the Section 409A provisions in Section 5.13, and the provisions of Section 3.6 and 5.3 thereof. This Agreement shall be governed by the terms of the Plan.
3.
No Consideration Absent Execution of this Agreement. Executive understands and agrees that Executive would not receive the consideration specified in Section 2, except for Executive’s execution and non-revocation of this Agreement and the fulfillment of the promises contained herein. Executive agrees and acknowledges that, as of the Separation Date, the Company has satisfied all of its obligations to Executive, including, without limitation, pursuant to the Employment Agreement and Executive has no further rights under the Employment Agreement.

2

4855-3238-1311v.2


4.
Mutual Release of Claims.
(a)
Executive’s Release of Claims. In exchange for the consideration provided to Executive pursuant to this Agreement, Executive, on behalf of Executive and all of Executive’s spouse, heirs, executors, administrators, successors, and assigns (collectively, “Executive Releasors”), hereby knowingly and voluntarily releases and forever waives and discharges the Company and/or its current and former parents, affiliates, subsidiaries, divisions, predecessor companies, related companies, their successors and assigns, their affiliated and predecessor companies and the current and former employees, attorneys, representatives, insurers, equityholders, owners, members, officers, general partners, limited partners, directors and agents thereof, and the current and former trustees or administrators of any pension or other benefit plan applicable to Executive or any other current or former executives of the Company, and investment funds or other investment vehicles managed by any of the foregoing and/or for which they perform services (collectively, with the Company, the “Company Group” and each a “Company Group Member”), and each Company Group Member’s respective current and former directors, members, trustees, controlling shareholders, subsidiaries, general partners, limited partners, affiliates, related companies, divisions, officers, employees, agents, insurers, representatives, and attorneys (collectively with the Company Group, referred to throughout the remainder of this Agreement as “Company Releasees,” and each a “Company Releasee”), of and from any and all claims, including statutory claims, regulatory claims and claims under this Agreement, demands, debts, obligations, promises, controversies, compensatory damages, liquidated damages, punitive or exemplary damages, any other damages, claims for costs and attorneys’ fees, rights, actions and causes of action, losses or liabilities of any nature whatsoever in law and in equity and any other claims, liabilities or matters, known or unknown, suspected or unsuspected, foreseen or unforeseen, whether accrued or contingent, which Executive or any of the other Releasors had, has or may have against the Company Releasees, or any of them, from the beginning of time through the Effective Date (defined below), including, but not limited to, by reason of, arising out of, connected with, or concerning Executive’s employment or service with the Company and/or separation from the Company, the Employment Agreement or Plan except claims that the law does not permit Executive or any of the Releasors to waive (collectively, the “Executive Released Claims”). Executive acknowledges that the Released Claims specifically include, but are not limited to, any and all claims for fraud, breach of express or implied contract, breach of the implied covenant of good faith and fair dealing, interference with contractual rights, violation of public policy, invasion of privacy, intentional or negligent infliction of emotional distress, whistleblowing laws, intentional or negligent misrepresentation, defamation, libel, slander, or breach of privacy; claims for failure to pay wages, benefits, deferred compensation, commissions, bonuses, vacation / PTO pay, expenses, severance pay, pay in lieu of notice, attorneys’ fees, or other compensation of any sort; claims related to equity or equity-based awards or costs, or other grants, awards, or warrants; claims related to any tangible or intangible property of Executive that remains with the Company; claims for retaliation, harassment or discrimination on the basis of race, color, sex, sexual orientation, national origin, ancestry, religion, age, disability, medical condition, marital status, gender identity, gender expression, or any other characteristic or criteria protected by law; any claim under Title VII of the Civil Rights Act of 1964 (Title VII, as amended), 42 U.S.C. §§ 2000e, et seq., the Civil Rights Act of 1991, the Civil Rights Act of 1866, the Family and Medical Leave Act (“FMLA”), 29 U.S.C. §§ 2601, et seq., the Age Discrimination in Employment Act (“ADEA”), 29 U.S.C. §§ 621 et seq., the Older Workers Benefit Protection Act, the Fair Labor Standards Act (“FLSA”), 29 U.S.C. §§ 201, et seq., the Equal Pay Act, 29 U.S.C.

3

4855-3238-1311v.2


§206(a), the Americans with Disabilities Act (“ADA”), 42 U.S.C. §§ 12101, et seq., the Consolidated Omnibus Budget Reconciliation Act of 1986 (“COBRA”), the Occupational Safety and Health Act (“OSHA”), the Uniformed Services Employment and Reemployment Rights Act (“USERRA”), 38 U.S.C. §§ 4301-4333, the Employee Retirement Income Security Act of 1974, as amended (“ERISA”), 29 U.S.C. §§ 301, et seq., the Vietnam Era Veterans Readjustment Act of 1974, the Immigration Reform and Control Act of 1986, 8 U.S.C. §§ 1101, et seq., the Equal Pay Act, the Labor Management Relations Act, the National Labor Relations Act, the Internal Revenue Code of 1986, as amended, the Worker Adjustment and Retraining Notification Act (“WARN”), 29 U.S.C. §§ 2101 et seq., the Genetic Information Nondiscrimination Act of 2008 (“GINA”) 42 U.S.C. §§ 2000ff, et seq., the Patient Protection and Affordable Care Act (“ACA”) 42 U.S.C. §§ 18001, et seq., all claims arising under the Sarbanes-Oxley Act of 2002 (Public Law 107-204), including whistleblowing claims under 18 U.S.C.§§ 1513(e) and 1514A, and any and all other foreign, federal, state, or local laws, common law, or case law, including but not limited to all statutes, regulations, common law, and any other applicable law, as such laws are amended from time to time.

This release is intended to be a general release and excludes only those claims under any statute or common law that Executive is legally barred from releasing, as well as (i) claims for workers’ compensation or unemployment benefits and vested retirement or welfare benefits, if any, under any Company sponsored plans; (ii) any right to enforce any term of this Agreement; (iii) any claims based on acts or events occurring after Executive signs this Agreement, except for claims arising from Executive’s employment or separation of employment with Company, which are being released by this Agreement; (iv) the right to file a charge or complaint with, or provide testimony, assistance or participation in, any investigation, proceeding or hearing conducted by any federal, state or local governmental agency, including but not limited to the EEOC; (v) the right to report violations of any law administered by the Occupational Safety and Health Administration (“OSHA”), the Securities and Exchange Commission (“SEC”), or make other disclosures protected under the whistleblower provisions of state or federal law; (vi) any of Executive’s claims, rights or entitlements related to or arising out of any of Executive’s restricted stock units or other stock options or equity holdings, vested or otherwise, as of the Separation Date under any agreement or plan between Executive and any Company Releasee, which, for the avoidance of doubt, includes all equity units maintained in the UP-C structure and the ownership rights of the Executive’s Tax Receivable Agreement (TRA); (vii) claims for indemnification pursuant to any duly executed agreement or plan between Executive and any Company Releasee, including the Indemnification Agreement dated February 4, 2021 (“Indemnification Agreement”); and (viii) any post-employment coverage for Executive under any Company Releasee insurance policy, including (without limitation) any D&O policy or EPL policy. Notwithstanding the foregoing, if an administrative agency or court assumes jurisdiction over any charge or complaint involving claims that are released by Section 4(a), Executive hereby agrees not to accept, recover, or receive any resulting money damages or other relief that otherwise would be due; provided that Executive may receive financial awards from OSHA, SEC, or any other federal agency for reporting possible violations of federal law or regulation in cases where the law prohibits Executives from waiving their rights to receive such payments.

(b)
Company Group’s Release of Claims. In exchange for the consideration provided to Company pursuant to this Agreement, each Company Group Member hereby knowingly and voluntarily releases and forever waives and discharges the Executive Releasors

4

4855-3238-1311v.2


from any and all claims, including statutory claims, regulatory claims and claims under this Agreement, demands, debts, obligations, promises, controversies, compensatory damages, liquidated damages, punitive or exemplary damages, any other damages, claims for costs and attorneys’ fees, rights, actions and causes of action, losses or liabilities of any nature whatsoever in law and in equity and any other claims, liabilities or matters, known or unknown, suspected or unsuspected, foreseen or unforeseen, whether accrued or contingent, which any Company Group Member had, has or may have against the Executive Releasors, or any of them, from the beginning of time through the Effective Date, including, but not limited to, by reason of, arising out of, connected with, or concerning Executive’s employment or service with the Company and/or separation from the Company or the Employment Agreement except claims that the law does not permit a Company Group Member to waive (collectively, the “Company Released Claims”).

The Company Group’s release is intended to be a general release and excludes only those claims under any statute or common law that a Company Group Member is legally barred from releasing, as well as (i) any rights to enforce the terms of this Agreement, including to enforce the terms of the Plan or the agreements referenced herein; (ii) any claims based on acts or events occurring after the Company signs this Agreement; (iii) claims for or relating to liability, damages or indemnification against Executive which are in any way based on any felony or other criminal conduct by Executive occurring during Executive’s employment; (iv) claims for or relating to violations of U.S. Federal or state securities laws or regulations by Executive or by the Company which were caused by the acts or omissions of Executive; (v) claims based on any fraud, intentional misrepresentation, misappropriation, embezzlement, bribery, forgery, theft, fiduciary duty, alleged violations of applicable statutes, regulations, or other laws by Executive, if and only to the extent any applicable law allows such claims to be brought against Executive personally (including, by way of example only, if Executive meets the definition of “employer” under applicable law in his individual capacity, such as (without limitation) 29 U.S.C. § 203(d)) in connection with his duties and responsibilities to the Company Group, whether such duties or responsibilities were purportedly rendered as an employee, officer or director; or, (vi) any Company Group Member’s claims, rights or entitlements related to or arising out of any of Executive’s restricted stock units or other stock options or equity holdings, vested or otherwise, as of the Separation Date under any agreement or plan between Executive and any Company Releasee, which, for the avoidance of doubt, includes all equity units maintained in the UP-C structure and the ownership rights of the Executive’s Tax Receivable Agreement (TRA). The Company Group’s release does not extend to any defenses to any claims that Executive is not releasing under this Agreement or to any claims that any third-parties may personally bring against Executive. Further, the Company will provide reasonable assistance (but shall not be required to incur any out-of-pocket expenses), at Executive’s request, with regard to tax information and liquidation of any such stock options or equity holdings of Executive.

5.
Consult With an Attorney. The Company hereby advises Executive to consult with an attorney of Executive’s choice (and at Executive’s expense) before Executive signs this Agreement.
6.
Affirmations. Executive represents and agrees by signing below that, other than the Severance Benefits set forth in Section 2 above, Executive (a) has not been denied any leave or benefit requested, and has received all compensation for all hours worked for the Company; (b) is not entitled to any compensation or benefits under any other severance policy or plan maintained

5

4855-3238-1311v.2


or followed by the Company; (c) has no known workplace injuries or occupational diseases; (d) is not aware of any alleged violations of the law or the Company’s agreements or policies by Executive or any other employee or other party that have not been reported in writing to the Company’s Chairperson of the Board of Directors; and (e) is not aware of wrongdoing by the Company or its officers, including any alleged corporate fraud that should be reported to authorities.
7.
Confidentiality. The Parties hereto agree that this Agreement and all matters relating to the terms and negotiation of this Agreement are Confidential Information and shall not be disclosed to any other person except as may be mutually agreed to in writing by the Parties, as may be compelled by a valid order of a court of competent jurisdiction, or as may be reasonably necessary to comply with the requirements of federal, state, or local authorities, regulators or codes (including Company disclosure obligations or securities filings), or as related and strictly limited to statements made as part of Executive’s testimony, assistance or participation in an administrative investigation described in Section 4(b) above. The Parties hereto agree that the terms of this Agreement may be disclosed to Executive’s immediate family and each of the Parties’ accounting, payroll, legal, financial, and tax professionals and the appropriate members of the Company’s management or ownership.
8.
Return of Company Property and Company Information. Executive agrees to return, on or before the Separation Date, or earlier if directed by the Company, any and all of Company’s property in Executive’s possession, as well as any and all records, files, correspondence, reports and computer disks relating to the Company’s operations, products and potential products, marketing, research and development, production and general business plans, customer information, accounting and financial information, distribution, sales, and confidential cost and price characteristics and policies in his possession (including on any personal computer).
9.
Non-Disclosure of Confidential Information.
(a)
The term “Confidential Information,” as used in this Agreement, shall mean any and all information (in whatever form and whether or not expressly designated as confidential) relating directly or indirectly to the respective businesses, operations, financial affairs, assets or technology of the Company, including, but not limited to, marketing and financial information, personnel, sales and statistical data, plans for future development, computer programs, information and knowledge pertaining to the products and services offered, inventions, innovations, designs, ideas, recipes, formulas, manufacturing processes, trade secrets, technical data, computer source codes, software, proprietary information, construction, advertising, manufacturing, distribution and sales methods and systems, pricing, sales and profit figures, customer and client lists, and relationships with customers, clients, suppliers, distributors and others who have business dealings with the Company and information with respect to various ingredients, formulas, manufacturing processes, techniques, procedures, processes and methods. Confidential Information also includes information received by Executive from third parties in connection with Executive’s employment by the Company subject to an obligation to maintain the confidentiality of such information. Confidential Information does not include information which (i) becomes generally known to and available for use by the public other than as a result of Executive’s violation of this Agreement; (ii) is or becomes generally available within the relevant business or industry other than as a result of Executive’s violation of this Agreement; or (iii) is or becomes available to Executive on a

6

4855-3238-1311v.2


nonconfidential basis from a source other than the Company, which source is not known by Executive, after reasonable inquiry, to be subject to a contractual or fiduciary obligation of secrecy to the Company.
(b)
Executive acknowledges and agrees that all Confidential Information known or obtained by Executive, whether before or after the Separation Date and regardless of whether Executive participated in the discovery or development of such Confidential Information, is the property of the Company. Except as expressly authorized in writing by the Company or as necessary to perform Executive’s services while an employee of the Company, Executive agrees that Executive will not, at any time, for any reason, directly or indirectly, duplicate, use, make available, sell, misappropriate, exploit, remove, copy or disclose Confidential Information, unless such information is required to be produced by Executive under order of a court of competent jurisdiction or a valid administrative or congressional subpoena; provided, however, that upon receipt of any such order or subpoena, Executive shall promptly notify the Company and shall provide the Company with an opportunity at its cost and expense to contest the propriety of such order or subpoena or restrict or condition the disclosure of such Confidential Information or to arrange for appropriate safeguards against any further disclosure by the court or administrative or other body seeking to compel disclosure of such Confidential Information.
10.
Whistleblower Protection. Nothing in this Agreement is intended to conflict with the whistleblower provisions of any United States federal, state or local law or regulation, including but not limited to Rule 21F-17 of the Securities Exchange Act of 1934 or § 1833(b) of the Defend Trade Secrets Act of 2016. Accordingly, notwithstanding anything to the contrary herein, nothing in this Agreement shall prohibit Executive from reporting possible violations of United States federal, state or local law or regulation to any United States federal, state or local governmental agency or entity, including but not limited to the Department of Justice, the Securities and Exchange Commission, the Congress, and any agency Inspector General, or to an attorney, or from making other disclosures that are protected under the whistleblower provisions of federal law or regulation, or from disclosing trade secrets and other confidential information in the course of such reporting; provided, that Executive uses Executive’s reasonable efforts to (a) disclose only information that is reasonably related to such possible violations or that is requested by such agency or entity and (b) requests that such agency or entity treat such information as confidential. Executive does not need the prior authorization from the Company to make any such reports or disclosures and is not required to notify the Company that it has made such reports or disclosures. In addition, Executive has the right to disclose trade secrets and other confidential information in a document filed in a lawsuit or other proceeding; provided, that the filing is made under seal and protected from public disclosure.
11.
Restrictive Covenants. Executive agrees that during Executive’s employment, Executive has had access to the Company’s Confidential Information. Such access and knowledge would put the Company at an unfair competitive disadvantage were Executive to use it on behalf of another person or entity. Therefore, during the twelve (12) month period following the Separation Date (the “Restriction Period”), Executive agrees that Executive shall not, directly or indirectly, for Executive’s own account, or on behalf of, or together with, any other Person (other than on behalf of the Company):

7

4855-3238-1311v.2


(a)
own, manage, operate, control, finance or participate in the ownership, management, operation, control or financing of, render financial assistance to, be connected as an officer, director, stockholder, employee, partner, member, manager, principal, agent, representative, consultant or otherwise with, use or permit Executive’s name to be used in connection with, or develop products or services for, any Competing Business anywhere in any state of the United States or any other jurisdiction in which the Company conducts business. “Competing Business” means any business and operations that are the same or similar to those performed by the Company Group for which Executive provides services or about which Executive obtains Confidential Information during Executive’s employment or service with the Company Group; notwithstanding the foregoing, it shall not be a breach of this Section 11(a) for Executive to own a passive investment of less than one percent (1%) of a class of stock of a publicly held company that is traded on a national securities exchange or in the over the counter market;
(b)
contact, solicit, induce or attempt to contact, solicit or induce any Person who is or was, within the one-year period prior to termination of Executive’s employment with the Company, a customer, supplier or agent of the Company or with which the Company or Executive had contact during Executive’s employment with the Company, to terminate their relationship with the Company, or do any act which may interfere with or result in the impairment of the relationship, including any reduction in sales or purchases, between the Company and such customers, suppliers or agents; or
(c)
contact, solicit, induce or attempt to contact, solicit or induce any Person who is or was, within the one-year period prior to termination of Executive’s employment with the Company, an employee of the Company for the purpose of seeking to have such employee terminate his or her employment with the Company.
(d)
Subject to Section 10, Executive will not, at any time during Executive’s employment with the Company or at any time thereafter, make any statement that is intended to disparage the Company Group or any of its businesses, products, services, directors or officers. The Board shall direct, in writing, the Company’s senior officers and directors, other members of the Company’s senior leadership team, and all the Company’s Board members not to make any statement that is intended to disparage the Executive. Executive acknowledges and agrees that the making of this direction shall satisfy such obligation, and the Company shall have no contractual liability in the event the direction is not followed, except that the Company shall take reasonable corrective action in the event that the Company obtains knowledge of the direction not being followed by a Company employee or Board member acting in his or her capacity for the Company or the Board. The foregoing shall not be violated by truthful statements in response to legal process, required governmental testimony or filings, or administrative or arbitral proceedings (including, without limitation, depositions in connection with such proceedings), and the foregoing limitation on Executive and the Board shall not be violated by statements that they in good faith believe are necessary or appropriate to make in connection with performing their duties and obligations to the Board or the Company.
(e)
In the event of a breach or threatened breach of Sections 7, 8, 9 or 11, as the sole exception to mandatory and exclusive arbitration as provided in Section 14, the Company may, in addition to other rights and remedies existing in its favor, apply to any court of competent jurisdiction for specific performance and/or temporary or permanent injunctive or other equitable

8

4855-3238-1311v.2


relief in order to enforce, or prevent any violations of, the provisions hereof (without posting a bond or other security), without the necessity of showing any actual damages or that money damages would not afford an adequate remedy. The aforementioned equitable relief shall be in addition to, not in lieu of, legal remedies, monetary damages or other available forms of relief. In addition to any other relief, the prevailing party in any such action shall be entitled to recover its costs and attorneys’ fees. If a court, or arbitrator, as the case may be in accordance with Section 14, holds that the duration, scope, or area restrictions stated herein are unreasonable, the Parties agree that such court, or arbitrator, as the case may be in accordance with Section 14, shall be allowed and directed to revise the restrictions to cover the maximum reasonable period, scope and area permitted by law.
(f)
For the avoidance of doubt, any post-employment restrictive covenant obligations Executive owes to the Company set forth in this Agreement are specifically and expressly in lieu of all post-employment restrictive covenants Executive owes under the Employment Agreement, Executive’s Employee Proprietary Information, Non-Solicitation and Arbitration Agreement (“Arbitration Agreement”), or otherwise, all of which are specifically waived by the Company and are of no further force or effect with respect to Executive after the Effective Date of this Agreement, save and except Executive’s obligations under the Plan, Executive’s intellectual property obligations and obligation to arbitrate covered claims under the Arbitration Agreement. Further, notwithstanding anything in this Section 11 to the contrary, the Company agrees that, for avoidance of doubt, the phrase “business and operations that are the same or similar to those performed by the Company Group” means such Company Group business and operations that equals more than two-and-one-half percent (2.5%) of the Company Group’s annual revenue as of the Separation Date. Further, notwithstanding anything in this Section 11 to the contrary, the Company also agrees that it shall not be a breach of this Section 11 for Executive to be employed by or provide services or assistance to any venture capital, investment management company, private equity company, or other business in the supply chain industry that is not a Competing Business for purposes of soliciting of investors or providing strategic advice for or in such business, provided that such solicitations do not materially damage or injure the business of the Company, and are not directly in reference to the Company Group. In addition, nothing in this Agreement shall prohibit the Executive from serving as a board member of any supply chain software companies that do not have any revenues related to any Company Group business or operations that equals more than two-and-one-half percent (2.5%) of the Company Group’s annual revenue as of the Separation Date, provided that Executive complies with the provisions of this Section 11. Notwithstanding anything to the contrary, Executive affirms Executive’s confidential information obligations under this Section 11 and further agrees not to directly or indirectly assist any person or entity in investing in, acquiring, or negotiating against the Company Group for three years following the Separation Date.
12.
Acknowledgments. Executive acknowledges and agrees that: (a) Executive has occupied a position of trust and confidence with the Company and has become familiar with Confidential Information; (b) the Confidential Information is of unique, very substantial and immeasurable value to the Company; (c) the Company has required that Executive make the covenants set forth in Sections 7 through 11 herein as a condition to the execution by the Company of this Agreement; (d) the provisions of Sections 7 through 11 are reasonable with respect to duration, geographic area and scope and necessary to protect and preserve the goodwill and ongoing business value of the Company, and will not, individually or in the aggregate, prevent

9

4855-3238-1311v.2


Executive from obtaining other suitable employment during the period in which Executive is bound by such provisions; (e) the scope of the business of the Company is independent of location (such that it is not practical to limit the restrictions contained in Sections 7 through 11 to a specified county, city or part thereof); (f) the Company would be irreparably damaged if Executive were to breach the covenants set forth in Sections 7 through 11; and (g) the potential benefits to Executive available under this Agreement are sufficient to compensate Executive fully and adequately for agreeing to the terms and restrictions of this Agreement.
13.
Termination of Benefits for Violating this Agreement. In the event Executive breaches or fails to abide by the terms of this Agreement, then in addition to any other remedies which the Company may have pursuant to this Agreement or in equity or at law, the Company has the right to permanently discontinue the Severance Benefits described in Section 2 above and obtain restitution of any benefits provided to, or on behalf of, Executive pursuant to this Agreement.
14.
Governing Law, Jurisdiction and Costs. The law of the State of Texas shall govern (a) all claims or matters related to or arising from this Agreement (including any tort or non-contractual claims) and (b) any questions concerning the construction, interpretation, validity and enforcement of this Agreement, without giving effect to any choice of law or conflict of law rules or provisions (whether of the State of Texas or any other jurisdiction) that would cause the application of the Law of any jurisdiction other than the State of Texas. Subject to Section 11(e), any and all disputes arising from or in connection with this Agreement, the Plan, or the Arbitration Agreement shall be subject to mandatory and exclusive arbitration pursuant to Section 10 of the Arbitration Agreement. Should a Party sue another Party in court for a breach of any provision of this Agreement, the prevailing Party, as determined by a court of competent jurisdiction under applicable law, is entitled to recover his/its reasonable attorneys’ fees, costs of court and other expenses of litigation, in addition to any other remedy.
15.
Severability/Modification. If any term, provision or paragraph of this Agreement is determined by a court, or arbitrator, as the case may be in accordance with Section 14, to be invalid or unenforceable for any reason, such court, or the arbitrator, as the case may be in accordance with Section 14, shall have the authority to reform and modify such term, provision or paragraph so as to render it enforceable while maintaining the Parties’ original intent (as reflected herein) to the maximum extent possible and such determination shall be limited to the narrowest possible scope in order to preserve the enforceability of the remaining portions of the term, provision or paragraph, and such determination shall not affect the remaining terms, provisions or paragraphs of this Agreement, which shall continue to be given full force and effect.
16.
No Admission of Wrongdoing. Neither this Agreement nor the furnishing of the consideration for this Agreement shall be deemed or construed at any time for any purpose as an admission by either of the Parties or any of the Company Releasees of any liability, or evidence of any liability, wrongful acts or unlawful conduct of any kind against Executive or any other person.
17.
Cooperation. During Executive’s employment with the Company, Executive acknowledges that Executive has been involved in business matters on behalf of the Company. As a further material inducement to the Company to make the payments described herein, after the

10

4855-3238-1311v.2


Separation Date, and subject to Section 1(b) above, Executive hereby agrees to, during normal business hours, (a) provide Executive’s full and timely cooperation to the Company regarding its business matters, specifically including but not limited to matters over which Executive had responsibility or in which Executive was involved, as well as any legal, equitable, or business matters or proceedings which involve the Company or any of its Executives, officers, or directors; (b) be reasonably available for questions or inquiries by phone, text, or email, and at the Company’s reasonable request for any meetings or conferences deemed necessary to assist the Company; (c) cooperate in the defense of any actual and potential claims, litigation, inquiry, investigation, or other matter, action, or proceeding filed against the Company or its officers, directors, employees or agents, including but not limited to, any actual or potential claims which may require Executive’s involvement post-employment; and (d) help transition Executive’s role and responsibilities to other Company personnel, and provide information in response to the Company’s requests and inquiries, in connection with Executive’s separation. The Company will pay reasonable travel and other expenses related to Executive’s cooperation in this regard, provided such expenses are pre-approved by the Board of Directors in writing. The Company agrees to provide reasonable advance notice of the need for Executive’s cooperation.
18.
Entire Agreement, Amendment and Construction. This Agreement, together with the Plan, Executive’s intellectual property obligations and obligation to arbitration covered claims under the Arbitration Agreement, Executive’s Indemnification Agreement, and Executive’s rights or entitlements related to or arising out of any of Executive’s restricted stock units or other stock options or equity holdings, vested or otherwise, as of the Separation Date under any agreement or plan between Executive and any Company Releasee, including (without limitation) any restricted stock unit agreements, award agreements, option agreements, the Company’s UP-C structure and Executive’s Tax Receivable Agreement (TRA), represents the entire agreement and understanding of the Parties, and no other oral or written agreements or representations exist. Notwithstanding anything to the contrary, Executive acknowledges and agrees that the Separation Date shall be used for purposes of measuring vesting of Executive’s restricted stock units and other stock options or equity holdings under the applicable governing documentation, and such stock units or other stock options or equity holdings shall not continue to vest thereafter, including during the Consulting Period and the E2open Parent Holdings, Inc. 2021 Omnibus Incentive Plan, As Amended, shall control. This Agreement may not be modified, altered or changed except in writing and signed by both Parties wherein specific reference is made to this Agreement. The captions appearing in this Agreement are inserted only as a matter of convenience and in no way define, limit, construe or describe the scope or intent of such Sections. This Agreement shall be construed without regard to the party that drafted it. The language used in this Agreement shall be deemed to be the language chosen by the Parties hereto to express their mutual intent, and no rule of strict construction shall be applied against any party. Any ambiguity shall not be interpreted against either party but shall, instead, be resolved in accordance with other applicable rules concerning the interpretation of contracts. The failure of the Company to enforce at any time any provision of this Agreement will in no way be construed to be a waiver of such provision or of any other provision hereof.
19.
Counterparts; Electronic Delivery. This Agreement may be executed and delivered in one or more counterparts and by fax, email or other electronic transmission, each of which to be deemed an original and all of which shall be considered one and the same agreement. No party shall raise the use of a fax machine or email to deliver a signature or the fact that any

11

4855-3238-1311v.2


signature or agreement or instrument was transmitted or communicated through the use of a fax machine or email as a defense to the formation or enforceability of this Agreement and each party forever waives any such defense.
20.
Assignment. Company and Company Releasees have the right to assign this Agreement, but Executive does not. This Agreement inures to the benefit of the successors and assigns of the Company and to the Company Releasees, who are intended third-party beneficiaries of this Agreement.
21.
Time to Consider and Revoke. Executive understands that Executive has up to twenty-one (21) days to consider the terms of this Agreement before signing it. Any modifications made to this Agreement, material or not, will not extend the twenty-one (21) days period. Executive must execute this Agreement no sooner than the Separation Date and no later than twenty-one (21) days immediately following the Separation Date. In addition, after Executive signs the Agreement, Executive has the right to revoke and cancel this Agreement for seven (7) days after Executive signs it. Any such revocation must be in writing and postmarked or delivered to the Company’s General Counsel, within seven (7) days of Executive’s signing this Agreement to be effective. This Agreement will be effective, fully binding, enforceable, and irrevocable upon the expiration of the seven-day period if Executive does not revoke it (the “Effective Date”). If Executive does not sign this Agreement, or signs it and then revokes Executive’s signature, this Agreement shall be null and void, and the Company shall have no obligation to provide or pay any of the consideration described in Section 2 above.
22.
Other Representations and Warranties. By executing this Agreement, Executive acknowledges that Executive: (i) is not relying upon any statements, understandings, representations, expectations, or agreements other than those expressly set forth in this Agreement; (ii) has made Executive’s own investigation of the facts and is relying solely upon Executive’s own knowledge; (iii) knowingly waives any claim that this Agreement was induced by any misrepresentation or nondisclosure and any right to rescind or avoid this Agreement based upon presently existing facts, known or unknown; (iv) is entering into this Agreement freely and voluntarily; (v) has carefully read and understood all of the provisions of this Agreement; and (vi) was provided the opportunity to discuss and did discuss all aspects of this Agreement with legal counsel of Executive’s choosing. The Parties stipulate that the Company is relying upon these representations and warranties in entering into this Agreement. These representations and warranties shall survive the execution of this Agreement.

12

4855-3238-1311v.2


IN WITNESS WHEREOF, the Parties hereto knowingly and voluntarily executed this Agreement as of the date set forth below:

E2OPEN PARENT HOLDINGS, INC.

 

 

 

/s/ Jennifer S. Grafton

Date:

October 10, 2023

 

MICHAEL FARLEKAS

 

 

 

/s/ Michael A. Farlekas

Date:

October 10, 2023

 

13

4855-3238-1311v.2


Exhibit 10.2

 

October 10, 2023

BY Email

Andrew Appel

Re: Terms of Employment

Dear Andrew:

The purpose of this letter agreement (this “Agreement”) is to set forth the terms of your employment with E2open Parent Holdings, Inc., a Delaware corporation (the “Company”).

1.
Term of Employment. The initial six-month term of your employment with the Company (the “Initial Term”) under the terms and conditions set forth in this Agreement will commence on October 10, 2023 (the “Effective Date”), subject to automatic monthly renewals (each, a “Renewal Term”) unless either party provides written notice of non-extension at least fifteen (15) days before the end of the Initial Term or any Renewal Term (the period of employment, including the Initial Term and any Renewal Terms, referred to herein as, the “Term”). Notwithstanding the foregoing, the Employment Term may be earlier terminated in accordance with Section 8 hereof.
2.
Title and Duties. You will serve as Interim Chief Executive Officer of the Company, and will have such duties and responsibilities typically associated with the position of Chief Executive Officer, together with such other duties and responsibilities consistent with your position as reasonably assigned to you from time to time by the Board of Directors of the Company (the “Board”). During the Term, you will also serve as a director on the Board. You also agree to serve as an officer and/or director of any other member of the Company Group (as defined below) during the Term, in each case, as reasonably determined by the Board, without any additional compensation. Your principal place of employment shall be in Chicago, Illinois, although you understand and agree that you will be required to travel from time to time for business reasons.
3.
Conduct During Employment. In connection with your employment with the Company, you agree to observe and comply with all of the rules, regulations, policies and procedures established by the Company or any of its direct or indirect subsidiary companies (collectively, the “Company Group”) from time to time and all applicable laws, rules and regulations imposed by any governmental regulatory authority from time to time. Without limiting the foregoing, you agree that during your employment with the Company, you will devote approximately 50% of your business time, attention, skill and best efforts to the performance of your employment duties. Nothing herein shall preclude you from (i) serving as a member of the boards of directors or advisory boards (or their equivalents in the case of a non-corporate entity) of non-competing businesses, (ii) engaging in charitable activities and community affairs, (iii) managing your personal investments and affairs and (iv) engaging in the permitted activities as set forth on Exhibit A hereto; provided, however, that the activities set out in clauses (i), (ii), (iii) and (iv) shall be

158931484v3


limited by you so as not to materially interfere, individually or in the aggregate, with the performance of your duties and responsibilities hereunder. You acknowledge and agree that during the Term, you will not commence any engagement or otherwise provide services to any company, entity or enterprise that is engaged in the business of providing cloud-based, end-to-end omni-channel and supply chain management and orchestration software.
4.
Base Salary. Your aggregate base salary for the Initial Term will be $500,000. After the expiration of the Initial Term, you will receive a monthly base salary of $83,333. Your base salary will be payable in ratable installments over the appliable period of the Term to which the salary relates in accordance with the Company’s regular payroll practices.
5.
Equity Awards. As soon as practicable following the Effective Date, you will receive an initial grant of restricted shares (the “Initial Restricted Stock Grant”) of Company common stock (“Shares”) under the E2open 2021 Omnibus Incentive Plan (the “Incentive Plan”) having an aggregate grant date value equal to approximately $685,000. Additionally, after the expiration of the Initial Term, during each Renewal Term, you will receive monthly grants of restricted Shares under the Incentive Plan, each having a grant date value of approximately $100,000 (each, a “Monthly Restricted Stock Grant”). The Initial Restricted Stock Grant and each Monthly Restricted Stock Grant will, in each case, be subject to approval by the Board and the terms and conditions of the Incentive Plan and the applicable restricted stock grant agreement, which will include applicable vesting terms that provide (x) in the case of the Initial Restricted Stock Grant, that the award will vest on the six-month anniversary of the Effective Date (y) in the case of each Monthly Restricted Stock Grant, that the award will vest on the one-month anniversary of such Monthly Restricted Stock Grant, and (z) in each case for fully accelerated vesting on the occurrence of the earlier of a Change in Control (as defined in the Incentive Plan) or termination of your employment with the Company without Cause.
6.
Benefits. You will be eligible to participate in health, insurance, retirement, paid time off and other benefits (excluding severance) provided to other executive officers of the Company in accordance with the Company’s benefit plans, programs and policies in effect from time to time. The Company otherwise expressly reserves the right to change the benefit plans, programs and policies it offers to its employees at any time.
7.
Reimbursement of Expenses. The Company shall pay (or promptly reimburse you) for documented, out-of-pocket expenses reasonably incurred by you in the course of performing your duties and responsibilities hereunder, which are consistent with the Company’s policies in effect from time to time with respect to business expenses, subject to the Company’s requirements with respect to reporting of such expenses.
8.
At-Will Employment. The nature of your employment at the Company is at-will, meaning that either the Company or you may terminate this Agreement and your employment at any time, with or without cause, and for any reason or for no reason, with fifteen (15) days prior written notice in the case of a termination without Cause (as defined herein), or with or without notice in the case of a termination for Cause. Upon any termination of your employment for any reason, except as otherwise provided for in Section 9 of this Agreement, no further payments by the Company to you will be due other than: (i) accrued but unpaid salary through the applicable date of your termination; (ii) any other accrued benefits to which you may be entitled pursuant to

2

158931484v3


the terms of benefit plans in which you participate at the time of such termination (excluding any employee benefit plan providing for severance or similar benefits), in accordance with the terms contained therein and (iii) any then unpaid amounts for the reimbursement of business expenses submitted in accordance with the Company’s policies and procedures. Further, upon any termination of your employment hereunder for any reason, except as may otherwise be requested by the Company in writing, you will immediately and without the need for any additional action be deemed to have resigned from all directorships, committee memberships, officer positions and any other positions that you hold with each member of the Company Group and agree to take any actions as may be reasonably required to effectuate the foregoing. Your execution of this Agreement will be deemed the grant by you to the officers of the Company of a limited power of attorney to sign in your name and on your behalf any such documentation as may be required to be executed solely for the limited purposes of effectuating such resignations.
9.
Severance. Subject to your execution and non-revocation of a release of claims in favor of the Company Group, if your employment is terminated by the Company for any reason other than for Cause, (x) if such termination occurs prior to the expiration of the Initial Term, (A) the Company will pay you an amount equal to the balance of any base salary that remains unpaid as of the date of termination that would have otherwise been payable in respect of the Initial Term, which amount will be paid within 30 days following the date of termination and (B) any portion of the Initial Restricted Stock Grant that has been granted that remains unvested as of the date of termination will become fully vested as of the date of termination, (y) if such termination occurs during any Renewal Term, any portion of any Monthly Restricted Stock Grant that has been granted that remains unvested as of the date of termination will become fully vested as of the date of termination and (z) if such termination occurs at any time during the Term, subject to your timely election of continuation coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”), continued participation (pursuant to COBRA) in the Company’s group health plan (to the extent permitted under applicable law and the terms of such plan), which covers you (and your eligible dependents) at the same premium rate applicable to you as of the date of termination until the later of (a) 12 months from date of termination or (b) December 31, 2024 (or, if earlier than either of the foregoing prongs (a) or (b), the date on which you obtain employment that offers group health benefits), provided, that that the Company may modify the continuation coverage contemplated by this Section 9(z) to the extent reasonably necessary to avoid the imposition of any excise taxes on the Company for failure to comply with the nondiscrimination requirements of Section 105(h) of the Internal Revenue Code of 1986, as amended; the Patient Protection and Affordable Care Act of 2010, as amended; and/or the Health Care and Education Reconciliation Act of 2010, as amended, and in each case, the regulations and guidance promulgated thereunder (to the extent applicable) (the entitlements under prongs (x), (y) and (z) together, the “Severance Benefit”).

In consideration for your opportunity to receive the Severance Benefit, you hereby acknowledge and agree that you are not eligible to participate in any other severance plans, programs policies or practices of the Company Group.

For purposes of this Agreement, “Cause” shall mean, in each case as reasonably determined in good faith by the the Board (a) your plea of nolo contendere to, or conviction of, any crime (whether or not involving any member of the Company Group) (i) constituting a felony or (ii) that has, or could reasonably be expected to result in, a material and adverse impact on the performance

3

158931484v3


of your duties to any member of the Company Group, or otherwise has, or could reasonably be expected to result in, a material and adverse impact on the business or reputation of any member of the Company Group; (b) your conduct, in connection with your employment or service, that has resulted, or could reasonably be expected to result, in material injury to the business or reputation of any member of the Company Group; (c) any material violation of the written policies of any member of the Company Group that have been acknowledged by you in writing (including electronic certification) as having been provided to you, including, but not limited to, those relating to sexual harassment, ethics, discrimination, or the disclosure or misuse of Confidential Information, or those set forth in the manuals or statements of policy of any member of the Company Group; (d) act(s) of gross negligence or willful misconduct in the course of your employment or service with any member of the Company Group; (e) misappropriation by you of any assets or business opportunities of any member of the Company Group; (f) embezzlement or fraud committed by you, at your direction, or with your prior actual knowledge; or (g) willful neglect in the performance of the your duties for any member of the Company Group or willful or repeated failure or refusal to perform such duties, in each case, except where you have a good faith basis to refuse to perform a directive of the Board where such action would be illegal or in violation of any Company Group policy. Notwithstanding the foregoing, prior to any termination of your employment for the reasons set forth in any of clauses (b), (c), (d), or (g) above, the Company must (1) provide you with written notice of the matter in question in reasonable detail, and (2) provide you fifteen (15) business days after the giving of such notice to cure any such matters (to the extent curable) to the satisfaction of the Board.

10.
Confidential Information. You agree at all times during the Term and thereafter, to hold in strictest confidence, and not to use, except for the benefit of the Company Group, or to disclose to any person, firm or company (except within the scope of your employment) without written authorization of the Chairman of the Board of the Company, any Confidential Information of the Company. You understand that “Confidential Information” means any Company Group proprietary information, technical data, trade secrets or know-how, including, but not limited to, research, product plans, products, services, customer lists and customers (including, but not limited to, customers of the Company Group on whom you called or with whom you became acquainted during the term of your employment), markets, software, developments, inventions, processes, formulas, technology, designs, drawings, engineering, computer programs, hardware configuration information, marketing, finances or other business information disclosed to you by the Company Group either directly or indirectly, in writing, orally, by drawings, or by observation of parts or equipment. You further understand that Confidential Information does not include any of the foregoing items which have become publicly known and made generally available through no wrongful act of yours or of others who were under confidentiality obligations as to the item or items involved. You also recognize and agree that you have no expectation of privacy with respect to Company Group’s telecommunications, networking or information processing systems (including, without limitation, stored computer files, email messages and voice messages) and that your activity and any files or messages on or using any of those systems may be monitored at any time without notice. Notwithstanding anything to the contrary herein, nothing in this Agreement is intended to limit your right (i) to discuss the terms, wages, and working conditions of your employment to the extent permitted and/or protected by applicable labor laws, (ii) to report Confidential Information in a confidential manner either to a federal, state or local government official or to an attorney where such disclosure is solely for the purpose of reporting or investigating a suspected violation of law, or (iii) to disclose Confidential Information in an

4

158931484v3


anti-retaliation lawsuit or other legal proceeding, so long as that disclosure or filing is made under seal and you do not otherwise disclose such Confidential Information, except pursuant to court order.
11.
Representations. By signing this Agreement, you represent and warrant to the Company that you are under no contractual commitments inconsistent with your obligations to the Company hereunder and that your acceptance of this offer of employment and your performance of the contemplated services hereunder does not and will not conflict with or result in any breach or default under any agreement, contract or arrangement to which you are a party to or violate any other legal restriction.
13.
Taxes. The Company may withhold from any payments made to you all applicable taxes, including but not limited to income, employment, and social insurance taxes, as required by law. You acknowledge and represent that the Company has not provided any tax advice to you in connection with this Agreement and you have been advised by the Company to seek tax advice from your own tax advisors regarding this Agreement and payments and benefits that may be made to you pursuant to this Agreement, including specifically, the application of the provisions of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”) to such payments. While the payments and benefits provided hereunder are intended to be structured in a manner to avoid the implication of any penalty taxes under Section 409A of the Code, in no event whatsoever will the Company Group be liable for any additional tax, interest or penalties that may be imposed on you as a result of Section 409A of the Code or any damages for failing to comply with Section 409A of the Code (other than for withholding obligations or other obligations applicable to employers, if any, under Section 409A of the Code).

Notwithstanding any provision in this Agreement to the contrary:

The payment (or commencement of a series of payments) of any nonqualified deferred compensation (within the meaning of Section 409A of the Code) upon a termination of employment will be delayed until such time as you have also undergone a “separation from service” as defined in Treas. Reg. 1.409A-1(h), at which time such nonqualified deferred compensation (calculated as of the date of your termination of employment) will be paid (or commence to be paid) to you on the schedule set forth in this Agreement as if you had undergone such termination of employment (under the same circumstances) on the date of your ultimate “separation from service.”
Any payment otherwise required to be made to you hereunder at any date as a result of the termination of your employment will be delayed for such period of time as may be necessary to meet the requirements of Section 409A(a)(2)(B)(i) of the Code (the “Delay Period”). On the first business day following the expiration of the Delay Period, you will be paid, in a single cash lump sum, an amount equal to the aggregate amount of all payments delayed pursuant to the preceding sentence and any remaining payments not so delayed will continue to be paid pursuant to the payment schedule set forth herein.
Each payment in a series of payments hereunder will be deemed to be a separate payment for purposes of Section 409A of the Code.

5

158931484v3


To the extent that any right to reimbursement of expenses or payment of any benefit in-kind under this Agreement constitutes nonqualified deferred compensation (within the meaning of Section 409A of the Code), (i) any such expense reimbursement shall be made by the Company no later than the last day of the taxable year following the taxable year in which such expense was incurred by you, (ii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit, and (iii) the amount of expenses eligible for reimbursement or in-kind benefits provided during any taxable year shall not affect the expenses eligible for reimbursement or in-kind benefits to be provided in any other taxable year; provided, that the foregoing clause shall not be violated with regard to expenses reimbursed under any arrangement covered by Section 105(b) of the Code solely because such expenses are subject to a limit related to the period the arrangement is in effect.
14.
[Reserved].
15.
Entire Agreement. This Agreement (together with the Incentive Plan, the Initial Restricted Stock Grant award agreement, and Monthly Restricted Stock Grant award agreements) forms the complete and exclusive statement of your employment with the Company and the compensation payable to you. For the avoidance of doubt, by entry into this Agreement you acknowledge and agree that the Advisory Board Service Member Agreement between you and the Company (A) effective as of August 4, 2022 and (B) effective as of April 12, 2023 (the “Advisory Agreement”) (with waiver of any notice provisions thereunder) shall, in the case of each of the foregoing prongs (A) and (B), be terminated as of the Effective Date. You further acknowledge and agree, that (x) as of the Effective Date, you are not owed any accrued compensation (cash, equity, incentive or otherwise) under the Advisory Agreement and (y) that you shall no longer be entitled to any cash, equity or incentive compensation thereunder following the Effective Date, other than the most recent installment of fees under the Advisory Agreement in the amount of $12,500, and any unreimbursed fees and expenses owed to you under the Advisory Agreement, both of which shall be paid to you on or promptly following the Effective Date; provided, that, any equity grants in respect of Company Shares made pursuant to the Advisory Agreement that are outstanding as of immediately prior to the Effective Date shall continue to vest pursuant to their respective terms during the Term and any subsequent period of your service to the Company as a member of the advisory board or the Board, or in any other capacity. This Agreement can only be modified in a written agreement signed by you and a properly authorized director or officer the Company.
16.
Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF ILLINOIS APPLICABLE TO CONTRACTS MADE AND TO BE PERFORMED ENTIRELY WITHIN SUCH STATE. BY EXECUTION OF THIS AGREEMENT, YOU ARE WAIVING ANY RIGHT TO TRIAL BY JURY IN CONNECTION WITH ANY SUIT, ACTION OR PROCEEDING UNDER OR IN CONNECTION WITH THIS AGREEMENT.
17.
Successors and Assigns. This Agreement shall inure to the benefit of the Company and its respective successors and assigns. Neither this Agreement nor any of the rights, obligations, or interests arising hereunder may be assigned by the Company to any person or entity (other than to any of the Company’s direct or indirect subsidiary companies) without your prior written

6

158931484v3


consent (which shall not be unreasonably withheld, delayed, or conditioned); provided, however, that in the event of a sale of all or substantially all of the assets of the Company, the Company shall provide that this Agreement be assigned to, and assumed by, the acquirer of such assets, it being agreed that in such circumstances, your consent will not be required in connection therewith. Your rights and obligations under this Agreement shall not be transferable by you by assignment or otherwise, without the prior written consent of the Company; provided, however, that if you die, all amounts then payable to you hereunder shall be paid in accordance with the terms of this Agreement to your devisee, legatee, or other designee, or if there be no such designee, to your estate.
18.
Survival. The provisions of this Agreement shall survive any termination of your employment to the extent necessary to give effect thereto.

* * *

[The remainder of this page is intentionally left blank]

7

158931484v3


 

If you agree with the terms and conditions of your employment as set forth herein, please sign the enclosed copy of this Agreement in the space indicated and return it to the Company. Your signature will acknowledge that you have read, understand and agree to the terms and conditions of this Agreement. This Agreement may be executed in two or more counterparts, each of which shall be deemed to be an original but all of which together shall constitute one and the same instrument. The execution of this Agreement may be by actual signature or by signature delivered by e-mail as a portable data format (.pdf) file or image file attachment.

Sincerely,

E2OPEN PARENT HOLDINGS, INC.

 

By:

/s/ Jennifer S. Grafton

Name:

Jennifer S. Grafton

Title:

EVP, General Counsel & Secretary

 

 

Acknowledged and agreed as of this 10th day of October 2023:

 

Signature:

/s/ Andrew Appel

Name:

Andrew Appel

 

8

158931484v3


 

Exhibit A

AppCapital, Founder and CEO

CC Capital, Adviser

Constant Contact, Lead Director

Cooler Screens, Adviser

Harmonya, Adviser

I-Genie.ai, Adviser

Premise, Adviser

Symphony Retail AI, Adviser

UCLA Anderson, School of Management, Advisory Board Member

Zeta Global, Adviser

A-1

158931484v3


Exhibit 10.3

E2OPEN PARENT HOLDINGS, INC.
RESTRICTED STOCK NOTICE
(2021 OMNIBUS INCENTIVE PLAN)

E2open Parent Holdings, Inc. (the “Company”), pursuant to its 2021 Omnibus Incentive Plan (the “Plan”), hereby grants to Participant an award of Restricted Stock in the amount set forth below (the “Award”). The Award is subject to all of the terms and conditions as set forth in this Restricted Stock Notice (this “Grant Notice”) and in the Restricted Stock Agreement (attached hereto as Attachment I) and the Plan, which has been made available to you on the Company Intranet, both of which are incorporated herein in their entirety. Capitalized terms not otherwise defined herein but defined in the Plan or the Restricted Stock Agreement will have the same definitions as in the Plan or the Restricted Stock Agreement. If there is any conflict between the terms in this Grant Notice and the Plan, the terms of the Plan will control.

Name of Participant:

Andrew Appel

Grant Date:

October 10, 2023

Number of shares of Restricted Stock:

[●]

 

Vesting Schedule:

The Restricted Stock will become unrestricted and fully vested on the [●]-month anniversary of the Grant Date (the “Vesting Date”), subject to Participant’s continued service through the Vesting Date; provided, however, the Restricted Stock will accelerate and vest in full upon the earlier to occur of (x) a termination of Participant’s employment by the Company without Cause (as such term is defined in the Offer Letter by and between Participant and the Company, dated as of October 10, 2023) and (y) a Change in Control, subject to Participant’s continued service through the date of such Change in Control.

 

 

Additional Terms/Acknowledgements: Participant acknowledges receipt of, and understands and agrees to, this Grant Notice, the Restricted Stock Agreement and the Plan. Participant acknowledges and agrees that this Grant Notice and the Restricted Stock Agreement may not be modified, amended or revised except as provided in the Plan. Participant further acknowledges that, as of the Grant Date, this Grant Notice, the Restricted Stock Agreement and the Plan set forth the entire agreement and understanding between Participant and the Company regarding the acquisition of Restricted Stock pursuant to the Award specified above and supersede all prior oral and written agreements, promises and/or representations on that subject with the exception of the Company’s clawback policy adopted in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act and any other compensation recovery policy adopted by the Company or is otherwise required by applicable law. By accepting this Award, Participant consents to receive such documents by electronic delivery and to participate in the Plan through an online or electronic system established and maintained by the Company or another third party designated by the Company.

1


 

E2OPEN PARENT HOLDINGS, INC.

PARTICIPANT:

By:

Jennifer S. Grafton

 

/s/ Andrew Appel

Signature

/s/ Jennifer S. Grafton

 

Andrew Appel

Title:

EVP, General Counsel & Secretary

 

 

Date:

October 10, 2023

Date:

October 10, 2023

 

ATTACHMENTS: Restricted Stock Agreement

2


 

ATTACHMENT I

E2OPEN PARENT HOLDINGS, INC.
2021 OMNIBUS INCENTIVE PLAN

RESTRICTED STOCK AGREEMENT

Pursuant to the Restricted Stock Grant Notice (the “Grant Notice”) and this Restricted Stock Agreement (this “Agreement”), E2open Parent Holdings, Inc. (the “Company”) has granted you an Award of Restricted Stock under its 2021 Omnibus Incentive Plan (the “Plan”) in the amount indicated in the Grant Notice. Capitalized terms not explicitly defined in this Agreement or in the Grant Notice but defined in the Plan will have the same definitions as in the Plan.

If there is any conflict between the terms in this Agreement and the Plan, the terms of the Plan will control. The details of your Award, in addition to those set forth in the Grant Notice and the Plan, are as follows:

1.
Grant of the Award. The Company has granted to you, as of the Grant Date, the number of shares of Restricted Stock specified in the Grant Notice. For purposes of this Agreement, the “Restriction Period” is the period beginning on the Grant Date and ending on the date the Restricted Stock is deemed unrestricted and vested under the terms set forth in the Grant Notice. You will be required to execute a stock power in favor of the Company, which will be cancelled upon lapse of restrictions with respect to the Restricted Stock. The Restricted Stock shall be held by the Company in electronic book entry form on the records of the Company’s transfer agent, together with the executed stock power, for your account until such restrictions lapse pursuant to the terms hereof, or such Restricted Stock is forfeited to the Company as provided by the Plan or this Agreement. You shall be entitled to the shares of Stock as to which such restrictions have lapsed, and the Company agrees to issue such shares of Stock in electronic form on the records of the transfer agent.
2.
Vesting. Subject to the limitations contained herein, your Award will vest as provided in your Grant Notice.
3.
Securities Law Compliance. The grant of Restricted Stock hereunder will be subject to, and will comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules and regulations (including, without limitation, the provisions of the Securities Act, the Exchange Act and in each case any respective rules and regulations promulgated thereunder) and any other law, rule regulation or exchange requirement applicable thereto. The issuance of Restricted Stock must also comply with all other applicable laws and regulations governing the Award and the Company’s policies, including without limitation the Company’s Insider Trading Policy, as amended from time to time. As a condition to the grant of Restricted Stock hereunder, the Company may require the Participant to satisfy any qualifications that may be necessary or appropriate to evidence compliance with any applicable law or regulation.
4.
Transfer Restrictions. The Restricted Stock, and any rights and interests with respect thereto, issued under this Agreement and the Plan shall not, prior to the expiration of the Restriction Period, be sold, exchanged, transferred, assigned or otherwise disposed of in any way by you (or any of your beneficiaries), other than by testamentary disposition by you or the laws of

3


 

descent and distribution. Any attempt to sell, exchange, transfer, assign, pledge, encumber or otherwise dispose of or hypothecate in any way any of the Restricted Stock, or the levy of any execution, attachment or similar legal process upon the Restricted Stock, contrary to the terms and provisions of this Agreement and/or the Plan shall be null and void and without legal force or effect.
5.
Section 409A. Notwithstanding anything herein or in the Plan to the contrary, the issuance of Restricted Stock is intended to be exempt from the applicable requirements of Treasury Regulation Section 1.409A-1(b)(4) and will be construed and administered in such a manner.
6.
Dividends. Cash dividends and stock dividends, if any, with respect to the Restricted Stock shall be withheld by the Company for your account, and shall be subject to forfeiture to the same degree as the Restricted Stock to which such dividends relate. Except as otherwise determined by the Committee, no interest will accrue or be paid on the amount of any cash dividends withheld.
7.
Restrictive Legends. The Company may, in its discretion, place a legend or legends on any electronic shares or certificates representing the Restricted Stock issued to you that the Company believes is required to comply with any law or regulation.
8.
Award Not A Service Contract. This Agreement is not an employment or service contract, and nothing in this Agreement will be deemed to create in any way whatsoever any obligation on your part to continue in the employ or service of the Company or an Affiliate, or of the Company or an Affiliate to continue your employment or service.
9.
Withholding Obligations.
a.
You hereby authorize any required withholding by the Company with respect to the Restricted Stock issued to you and/or otherwise agree to make adequate provision in cash for any sums required to satisfy the federal, state, local and foreign tax withholding obligations of the Company or any Affiliate that arise in connection with your Award (the “Withholding Taxes”). Additionally, the Company or any Affiliate may, in its sole discretion, satisfy all or any portion of the Withholding Taxes obligation relating to your Award by any of the following means or by a combination of such means: (i) withholding from any compensation otherwise payable to you by the Company; (ii) causing you to tender a cash payment; or (iii) withholding shares of Stock otherwise issuable to you in connection with the Award with a Fair Market Value equal to the amount of such Withholding Taxes.
10.
Section 83(b). You and the Company hereby agree that you may, within 30 days following the Grant Date of this Award, file with the Internal Revenue Service an election under Section 83(b) of the Internal Revenue Code. In the event you make such an election, you agree to provide a copy of the election to the Company. You acknowledge that you are responsible for obtaining the advice of your tax advisors with regard to the Section 83(b) election and that you are relying solely on such advisors and not on any statements or representations of the Company or any of its agents with regard to such election.
11.
Tax Consequences. You hereby agree that the Company does not have a duty to design or administer the Plan or its other compensation programs in a manner that minimizes your

4


 

tax liabilities. You will not make any claim against the Company, or any of its officers, directors, employees or Affiliates related to tax liabilities arising from your Award or your other compensation.
12.
Notices. Any notices provided for in your Award or the Plan will be given in writing (including electronically) and will be deemed effectively given upon receipt or, in the case of notices delivered by mail by the Company to you, five (5) days after deposit in the United States mail, postage prepaid, addressed to you at the last address you provided to the Company. The Company may, in its sole discretion, decide to deliver any documents related to participation in the Plan and this Award by electronic means or to request your consent to participate in the Plan by electronic means. By accepting this Award, you consent to receive such documents by electronic delivery and to participate in the Plan through an on-line or electronic system established and maintained by the Company or another third party designated by the Company.
13.
Governing Plan Document. Your Award is subject to all the provisions of the Plan, the provisions of which are hereby made a part of your Award, and is further subject to all interpretations, amendments, rules and regulations which may from time to time be promulgated and adopted pursuant to the Plan. If there is any conflict between the provisions of your Award and those of the Plan, the provisions of the Plan will control. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE. ANY DISPUTE, CONTROVERSY OR CLAIM BETWEEN YOU AND THE COMPANY ARISING OUT OF OR RELATED TO THIS AGREEMENT SHALL BE RESOLVED BY ARBITRATION IN ACCORDANCE WITH THE PROVISIONS RELATING TO ARBITRATION SET FORTH IN THE PLAN.
14.
Clawback/Recoupment Policy. Your Award (and any compensation paid or shares issued under your Award) is subject to recoupment in accordance with the Company’s clawback policy adopted in accordance with the Dodd-Frank Wall Street Reform and Consumer Protection Act and any other compensation recovery policy adopted by the Company or is otherwise required by applicable law.
15.
Other Documents. You hereby acknowledge receipt of and the right to receive a document providing the information required by Rule 428(b)(1) promulgated under the Securities Act, which includes the Plan prospectus. In addition, you hereby acknowledge receipt of the Company’s Code of Conduct and Ethics and Insider Trading Policy, each, as in effect from time to time, which, among other things, prohibit certain individuals from selling shares during certain “black-out” periods.
16.
Effect On Other Employee Benefit Plans. The value of this Award will not be included as compensation, earnings, salaries, or other similar terms used when calculating your benefits under any employee benefit plan sponsored by the Company or any Affiliate, except as such plan otherwise expressly provides. The Company expressly reserves its rights to amend, modify, or terminate any of the Company’s or any Affiliate’s employee benefit plans.
17.
Voting Rights. You may exercise full voting rights with respect to the Restricted Stock granted hereunder.

5


 

18.
Severability. If all or any part of this Agreement or the Plan is declared by any court or governmental authority to be unlawful or invalid, such unlawfulness or invalidity will not invalidate any portion of this Agreement or the Plan not declared to be unlawful or invalid. Any Section of this Agreement (or part of such a Section) so declared to be unlawful or invalid shall, if possible, be construed in a manner which will give effect to the terms of such Section or part of a Section to the fullest extent possible while remaining lawful and valid.
19.
Data Privacy. You explicitly and unambiguously consent to the collection, use, and transfer, in electronic or other form, of personal data as described in Section 20(g) of the Plan (such Section 20(g) of the Plan is incorporated herein by reference and made a part hereof) by and among, as applicable, the Company, its Affiliates, third-party administrator(s) and other possible recipients for the exclusive purpose of implementing, administering, and managing the Plan and Awards and your participation in the Plan. You acknowledge, understand and agree that Data may be transferred to third parties, which will assist the Company with the implementation, administration and management of the Plan.
20.
Miscellaneous.
a.
The rights and obligations of the Company under your Award will be transferable to any one or more persons or entities, and all covenants and agreements hereunder will inure to the benefit of, and be enforceable by, the Company’s successors and assigns.
b.
You agree upon request to execute any further documents or instruments necessary or desirable in the sole determination of the Company to carry out the purposes or intent of your Award.
c.
You acknowledge and agree that you have reviewed your Award in its entirety, have had an opportunity to obtain the advice of counsel prior to executing and accepting your Award and fully understand all provisions of your Award.
d.
This Agreement will be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.
e.
All obligations of the Company under the Plan and this Agreement will be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and/or assets of the Company.

This Agreement will be deemed to be signed by you upon the signing by you of the Grant Notice to which it is attached.

6


 

Exhibit 99.1

www.e2open.com

Press Release

E2open Announces Executive Transition

Board of Directors and Michael Farlekas reach mutual decision for new leadership

Andrew Appel appointed Interim Chief Executive Officer

AUSTIN – October 10, 2023 – E2open Parent Holdings, Inc. (NYSE: ETWO), the connected supply chain SaaS platform with the largest multi-enterprise network, today announced that its board of directors and Michael Farlekas have reached a mutual decision that the time is right for new leadership. Accordingly, the e2open board of directors has initiated an external search process to identify a new permanent chief executive officer and has retained a leading executive search firm. In the meantime, the board has named Andrew Appel as interim chief executive officer and appointed him to the board of directors, effective immediately.

Appel, who has served on e2open’s advisory board for more than a year, has extensive experience in the technology industry as well as proven expertise in business strategy and innovation. He previously served as president and chief executive officer at IRI, a leading provider of big data, predictive analytics, and forward-looking insights. During his tenure at IRI, he oversaw the launch of multiple transformative initiatives that repositioned the company as the innovation leader for consumer packaged goods brands, retailers, and media companies. Prior to joining IRI, he served as chief revenue officer of Accretive Health, chief operating officer of Aon, and was a senior partner at McKinsey & Company.

Chinh E. Chu, chairman of the e2open board of directors, said, “We are fortunate to have Andrew take on this interim role given his deep experience with connected enterprise software solutions combined with his leadership and financial skills. Andrew is well-positioned to continue our core mission of providing the most comprehensive and impactful end-to-end supply chain software platform combining networks, data, and applications. While a search for a full-time CEO is underway, the board has full confidence in Andrew and the leadership team to guide the company through this transition.

“On behalf of the entire board, I want to thank Michael for his many contributions to e2open over the past eight years. We appreciate his hard work growing the company into a mission-critical platform for the world’s largest and most important companies. We wish him all the best in his future endeavors.”

About e2open

E2open is the connected supply chain software platform that enables the world’s largest companies to transform the way they make, move, and sell goods and services. With the broadest cloud-native global platform purpose-built for modern supply chains, e2open connects more than 420,000 manufacturing, logistics, channel, and distribution partners as one multi-enterprise network tracking over 14 billion transactions annually. Our SaaS platform anticipates disruptions and opportunities to help companies improve efficiency, reduce waste, and operate sustainably. Moving as one. Learn More: www.e2open.com.

9600 Great Hills Trail, Suite 300E, Austin, TX 78759 | Tel. 1.512.425.3500 | e2open.com
Copyright
E2open, LLC. All rights reserved. CONFIDENTIAL


 

 



 

E2open and “Moving as one.” are the registered trademarks of E2open, LLC. All other trademarks, registered trademarks and service marks are the property of their respective owners.

 

###

 

 

Contacts

Media Contact:

5W PR for e2open

e2open@5wpr.com

212.584.4307

 

Investor Relations Contact:

Dusty Buell

dusty.buell@e2open.com

investor.relations@e2open.com

 

Corporate Contact:

Kristin Seigworth

VP Communications, e2open

kristin.seigworth@e2open.com

pr@e2open.com

 

 

9600 Great Hills Trail, Suite 300E, Austin, TX 78759 | Tel. 1.512.425.3500 | e2open.com
Copyright
2022 E2open, LLC. All rights reserved. CONFIDENTIAL